Evaluation of Group Lifestyle Balance Maintenance Strategies

Completed · Not applicable

Conditions studied: Diabetes

In brief

Heart disease is a leading cause of death in people in the United States. It is a major problem for those with diabetes. Conditions called the metabolic syndrome and pre-diabetes increase risk for diabetes and heart disease. The metabolic syndrome is a group of disorders that occur at the same time. Overall, one in four American adults has the metabolic syndrome. It is more common in people over the age of 40. The metabolic syndrome includes: 1) large waist size, 2) high triglycerides, 3) low HDL cholesterol, 4) high blood pressure and 5) high fasting blood sugar. People with the metabolic syndrome have at least three of these five risk factors. Pre-diabetes is considered to be present in those with high fasting blood sugar levels below the diabetes range. Research has shown that type 2 diabetes and the metabolic syndrome may be prevented or delayed by making lifestyle changes. It is not known what will most help people continue these healthy changes over time. The purpose of this study is to look at ways to help people continue the healthy lifestyle changes they have made while taking part in a diabetes prevention program called Group Lifestyle Balance (GLB).

Key facts

Study ID

NCT00869609

Run by

University of Pittsburgh

People needed

60

Starts

2009-03-01

Expected to finish

2010-08-01

Last updated by the study team

2016-06-24

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Non-diabetic patients with metabolic syndrome AND/OR pre-diabetes are eligible for this project based on the following criteria:
• Metabolic Syndrome:
• Patients with BMI ≥ 25 kg/m2, with at least 3 of the following risk factors for metabolic syndrome:
• Waist circumference (>40 inches men, >35 inches women)
• Blood pressure ≥130 mmHg (systolic) or ≥85 mmHg (diastolic) OR history of diagnosed hypertension
• Low HDL level (<40mg/dL men, <50 mg/dL women)
• Elevated triglyceride level ≥150 mg/dL
• Fasting glucose ≥100mg/dL and <126mg/dL
• Pre-diabetes:
• Patients with a BMI ≥25 kg/m2 and pre-diabetes (fasting glucose ≥100 mg/dL and <126mg/dL)
• All measures should have been taken within one year of enrollment into the study. A permission for physical activity form must be signed by the participant's physician in order to take part in the study.

You may not qualify if…

• Previous diabetes or diabetes diagnosed as a result of the screening
• Age <18 years old
• Women who are currently (or within past 6-weeks) pregnant or lactating
• Any patient deemed by their physician not to be a candidate
• Any patient planning to leave the area before the end of the GILS
• Any patient who is unable to provide informed consent

Where it is running

• Diabetes Prevention Support Center — Pittsburgh, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.